TASK FORCE TO STUDY USES OF
METHYLPHENIDATE & OTHER DRUGS ON SCHOOL CHILDREN

Sidney B. Seidman, M.D., Chair (chosen by Governor)

Appointed by Governor: Harolyn M. E. Belcher, M.D.; Gail I. Dunlap; John A. Grant, M.D.; David Humbert; Linda J. Jacobs, Ed.D.; Theo E. Lemaire, Ph.D.; Pamela J. Lewis; Patricia H. Michel; B. Pauline Prince, Ph.D.; Geneva Rawls; Mark A. Riddle, M.D.; Mary H. Shiner; Larry B. Silver, M.D.; Kenneth Tellerman, M.D.; Julie M. Zito, Ph.D.

Appointed by Senate President: Paula C. Hollinger

Appointed by House Speaker: Dan K. Morhaim

Appointed by State Board of Physician Quality Assurance: Sidney B. Seidman, M.D.

Appointed by State Board of Examiners of Psychologists: Milton Shore, Ph.D.

Staff: Cheryl Duncan, M.D. (410) 767-6749
William Flook, Ph.D. (410) 767-0307

c/o Office of Children's Health
Community & Public Health Administration
Dept. of Health & Mental Hygiene
201 West Preston St.
Baltimore, MD 21201 - 2399
(410) 767-6749

In 1997, the Task Force to Study Uses of Methylphenidate and Other Drugs on School Children was formed (Chapter 504, Acts of 1997).

The Task Force is to determine the extent to which methylphenidate (ritalin) is prescribed for school-age children in Maryland, by whom, and why. The Task Force will consider what other treatments for attention-deficit hyperactivity disorder are available and generally used. Educational programs and materials on the disorder will be developed by the Task Force for parents, educators, and primary care physicians. The Task Force also will convene a State conference on the attention-deficit hyperactivity disorder; and the use of methylphenidate, dextroamphetamine, magnesium pemoline and other medications for its treatment, as well as nonpharmacological treatment alternatives.

Authorization for the Task Force ends January 1, 1999.

Maryland Executive Commissions, Committees, Task Forces, & Advisory Boards

Maryland Manual On-Line